APA (7th ed.) Citation

Kyte, J. A., Aamdal, S., Dueland, S., Sæbøe-Larsen, S., Inderberg, E. M., Madsbu, U. E., . . . Kvalheim, G. (2016). Immune response and long-term clinical outcome in advanced melanoma patients vaccinated with tumor-mRNA-transfected dendritic cells. Oncoimmunology, 5(11), e1232237. https://doi.org/10.1080/2162402X.2016.1232237

Chicago Style (17th ed.) Citation

Kyte, Jon Amund, Steinar Aamdal, Svein Dueland, Stein Sæbøe-Larsen, Else Marit Inderberg, Ulf Erik Madsbu, Eva Skovlund, Gustav Gaudernack, and Gunnar Kvalheim. "Immune Response and Long-term Clinical Outcome in Advanced Melanoma Patients Vaccinated with Tumor-mRNA-transfected Dendritic Cells." Oncoimmunology 5, no. 11 (2016): e1232237. https://doi.org/10.1080/2162402X.2016.1232237.

MLA (9th ed.) Citation

Kyte, Jon Amund, et al. "Immune Response and Long-term Clinical Outcome in Advanced Melanoma Patients Vaccinated with Tumor-mRNA-transfected Dendritic Cells." Oncoimmunology, vol. 5, no. 11, 2016, p. e1232237, https://doi.org/10.1080/2162402X.2016.1232237.